IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 83 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $26,000 | -56.7% | 15,076 | -38.3% | 0.02% | -52.0% |
| Q1 2017 | $60,000 | +27.7% | 24,417 | -22.0% | 0.05% | +163.2% |
| Q4 2016 | $47,000 | +571.4% | 31,319 | +1046.4% | 0.02% | +280.0% |
| Q3 2016 | $7,000 | +600.0% | 2,732 | +413.5% | 0.01% | +400.0% |
| Q2 2016 | $1,000 | – | 532 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,030,604 | $4,285,000 | 0.70% |
| Virtus ETF Advisers LLC | 180,348 | $381,000 | 0.48% |
| Bain Capital Public Equity Management, LLC | 4,564,744 | $9,632,000 | 0.35% |
| Baker Brothers Advisors | 18,315,802 | $38,646,000 | 0.34% |
| Stanley-Laman Group, Ltd. | 483,773 | $1,021,000 | 0.22% |
| FIRST MIDWEST BANK TRUST DIVISION | 493,689 | $1,042,000 | 0.13% |
| GMT CAPITAL CORP | 3,875,546 | $8,178,000 | 0.08% |
| Vident Investment Advisory, LLC | 640,270 | $1,351,000 | 0.06% |
| SABBY MANAGEMENT, LLC | 307,987 | $650,000 | 0.06% |
| Palo Alto Investors LP | 616,355 | $1,301,000 | 0.06% |